Global Hidradenitis Suppurativa Market Report 2024

Hidradenitis Suppurativa Global Market Report 2024 – By Skin Condition (Folliculitis, Pimples, Boils, Deep-Acne), By Product (Tablet, Intravenous (IV) Injection), By Route Of Administration (Oral, Parenteral), By Treatment (Medications, Surgery, Photodynamic Therapy (PDT), Laser Treatment, Other Treatments), By End User (Hospital, Specialty Clinic, Homecare, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Hidradenitis Suppurativa Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Hidradenitis Suppurativa Market Definition And Segments

Hidradenitis suppurativa (HS) is a chronic skin condition that causes painful lumps deep in the skin, usually on parts of the body where skin touches the skin, like the armpits, inner thighs, and groin area. These lumps frequently appear where skin contacts skin, such as the armpits, inner thighs, and groin.

The main types of skin conditions in hidradenitis suppurativa are folliculitis, pimples, boils, and deep acne. Folliculitis refers to a common skin condition that occurs when hair follicles become inflamed or infected, and various types of treatments are used for folliculitis, such as creams, pills, and laser hair removal treatments. The product types included are tablets and intravenous (IV) injections, which are administered through oral and parenteral routes in treatments such as medications, surgery, photodynamic therapy (PDT), laser treatment, and others. The end users are hospitals, specialty clinics, homecare, and others.

The hidradenitis suppurativa market covered in this report is segmented –

1) By Skin Condition: Folliculitis, Pimples, Boils, Deep-Acne

2) By Product: Tablet, Intravenous (IV) Injection

3) By Route Of Administration: Oral, Parenteral

4) By Treatment: Medications, Surgery, Photodynamic Therapy (PDT), Laser Treatment, Other Treatments

5) By End User: Hospital, Specialty Clinic, Homecare, Other End Users

The hidradenitis suppurativa market size has grown strongly in recent years. It will grow from $1.06 billion in 2023 to $1.15 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increased diagnosis awareness, limited treatment options, advancements in dermatology, rising disease prevalence, patient advocacy initiatives.

The hidradenitis suppurativa market size is expected to see strong growth in the next few years. It will grow to $1.5 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to biologic therapies development, precision medicine approaches, clinical trial expansion, global initiatives and funding, healthcare policy support. Major trends in the forecast period include advanced immunomodulatory therapies, telemedicine and remote monitoring, patient-centric care, minimally invasive surgical interventions, personalized lifestyle recommendations.

The Rise In The Prevalence Of Skin Diseases

The rise in the prevalence of skin diseases is driving the growth of the hidradenitis suppurativa market going forward. Skin diseases refer to a wide range of skin problems, including those attributed to bacterial infections, viral infections, fungal infections, allergy symptoms, skin malignancies, and parasites. Hidradenitis suppurativa (HS), a chronic and severe skin disorder, is driving the development of new products and services for its management due to increased awareness, accurate diagnosis, a growing patient pool, and research advancements. For instance, in January 2022, according to the report published by the American Cancer Society Inc., a US-based voluntary organization for cancer awareness, the estimated cases of skin cancer increased to 106,110 in 2021, an increase of 5.8% from 100,350 in 2020. Therefore, the rise in the prevalence of skin diseases propels the growth of the hidradenitis suppurativa market.

Increasing Healthcare Expenditure

Increasing healthcare expenditure is driving the growth of the hidradenitis suppurativa market going forward. Healthcare expenditure refers to an expense that covers all costs associated with providing health services, family planning, nutrition, and emergency help with a focus on health. Increasing healthcare expenditure also allows for the creation of comprehensive patient support programs, ensuring better management of hidradenitis suppurativa and an overall positive impact on the quality of care and research in the field. For instance, in March 2022, according to the 2021–2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based Department of Health and Human Services department, the annual increase in national health spending was predicted to average 5.1% between 2021 and 2030, reaching approximately $6.8 trillion by 2030. Therefore, increasing healthcare expenditure propels the growth of the hidradenitis suppurativa market.

Major companies operating in the hidradenitis suppurativa market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, UCB S.A., Incyte Corporation, Kyowa Kirin Co. Ltd., Leo Pharma A/S, Almirall S.A., Galapagos NV, Genentech Inc., Tolmar Inc., Alvotech Holdings S.A., Aclaris Therapeutics Inc., Kymera Therapeutics Inc., Acelyrin Inc., AnaptysBio Inc., XBiotech Inc., Arcutis Biotherapeutics Inc., InflaRx N.V., VYNE Therapeutics Inc., Arena Pharmaceuticals Inc., MoonLake Immunotherapeutics AG, Zynerba Pharmaceuticals Inc.

Transforming Hidradenitis Suppurativa Treatment Through Innovative Therapies

Utilization of biologics is a key trend gaining popularity in the hidradenitis suppurativa market. Major companies operating in the hidradenitis suppurativa market are investing in research and development, resulting in an approved biologic therapy for hidradenitis suppurativa and sustaining their position in the market. For instance, in June 2023, the European regulatory authority approved Novartis AG, a Switzerland-based pharmaceutical company, for Cosentyx for hidradenitis suppurativa. Cosentyx is the first and only completely human biologic that specifically blocks interleukin-17A, an essential cytokine associated with hidradenitis suppurative disease. Cosentyx is a well-established medication that has been clinically researched for over 14 years.

Novartis Partners With Emirates Dermatology Society To Advance Hidradenitis Suppurativa Awareness

Strategic partnerships are the key trend gaining popularity in hidradenitis suppurativa market. Major companies operating in hidradenitis suppurativa market are focused on forming strategic alliances to strengthen their position in the market. For instance, in June 2023, Novartis, a Switzerland based pharma company entered a partnership with a UAE based in the continuous improvement in the quality of dermatology services Emirates Dermatology Society (EDS), to take on Hidradenitis Suppurativa awareness in the UAE. The collaboration will also deliver insights to help healthcare providers and policymakers support patients affected by the debilitating disease. Novartis and EDS will establish scientific, educational platforms targeting dermatologists and patients in the UAE. Both organizations will capture and generate local data on hidradenitis suppurativa through Real World Evidence (RWE).

Amgen Acquires Chemocentryx Elevating Treatment Portfolio

In October 2022, Amgen Inc., a US-based biopharmaceutical company, acquired ChemoCentryx Inc. for $3.7 billion. Through this acquisition, Amgen Inc. enhances its market position by adding TAVNEOS from ChemoCentryx to its product portfolio. TAVNEOS, an FDA-approved gastrointestinal-restricted complement 5a receptor inhibitor, is a potential complementary therapy for individuals with hidradenitis suppurativa. ChemoCentryx, Inc., is a US-based biopharmaceutical company specializing in medications for autoimmune and oncology diseases such as hidradenitis suppurativa.

North America was the largest region in the hidradenitis suppurativa market in 2023. The regions covered in the hidradenitis suppurativa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hidradenitis suppurativa market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The hidradenitis suppurativa (HS) market consists of revenues earned by entities providing treatment to axillary-mammary-inguinal hidradenitis suppurativa, follicular hidradenitis suppurativa, gluteal hidradenitis suppurativa, and syndromic hidradenitis suppurativa. The market value includes the value of related goods sold by the service provider or included within the service offering. The hidradenitis suppurativa (HS) market also includes sales of surgery biologics, antibiotics, immunosuppressive drugs, zinc supplements, and retinoids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The hidradenitis suppurativa (HS) research report is one of a series of new reports from The Business Research Company that provides hidradenitis suppurativa (HS) market statistics, including the hidradenitis suppurativa (HS) industry's global market size, regional shares, competitors with an hidradenitis suppurativa (HS) market share, detailed hidradenitis suppurativa (HS) market segments, market trends and opportunities, and any further data you may need to thrive in the hidradenitis suppurativa (HS) industry. This hidradenitis suppurativa (HS) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Hidradenitis Suppurativa Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $1.15 billion
Revenue Forecast In 2033 $1.5 billion
Growth Rate CAGR of 6.8% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Skin Condition: Folliculitis, Pimples, Boils, Deep-Acne
2) By Product: Tablet, Intravenous (IV) Injection
3) By Route Of Administration: Oral, Parenteral
4) By Treatment: Medications, Surgery, Photodynamic Therapy (PDT), Laser Treatment, Other Treatments
5) By End User: Hospital, Specialty Clinic, Homecare, Other End Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Novartis AG; Bristol-Myers Squibb Company; AstraZeneca PLC; Abbott Laboratories; Eli Lilly and Co Ltd.; Amgen Inc.; Boehringer Ingelheim International GmbH; UCB S.A.; Incyte Corporation; Kyowa Kirin Co. Ltd.; Leo Pharma A/S; Almirall S.A.; Galapagos NV; Genentech Inc.; Tolmar Inc.; Alvotech Holdings S.A.; Aclaris Therapeutics Inc.; Kymera Therapeutics Inc.; Acelyrin Inc.; AnaptysBio Inc.; XBiotech Inc.; Arcutis Biotherapeutics Inc.; InflaRx N.V.; VYNE Therapeutics Inc.; Arena Pharmaceuticals Inc.; MoonLake Immunotherapeutics AG; Zynerba Pharmaceuticals Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Hidradenitis Suppurativa Market Characteristics

    3. Hidradenitis Suppurativa Market Trends And Strategies

    4. Hidradenitis Suppurativa Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Hidradenitis Suppurativa Market Size and Growth

    5.1. Global Hidradenitis Suppurativa Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Hidradenitis Suppurativa Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Hidradenitis Suppurativa Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Hidradenitis Suppurativa Market Segmentation

    6.1. Global Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Folliculitis

    Pimples

    Boils

    Deep-Acne

    6.2. Global Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Tablet

    Intravenous (IV) Injection

    6.3. Global Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oral

    Parenteral

    6.4. Global Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Medications

    Surgery

    Photodynamic Therapy (PDT)

    Laser Treatment

    Other Treatments

    6.5. Global Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital

    Specialty Clinic

    Homecare

    Other End Users

    7. Hidradenitis Suppurativa Market Regional And Country Analysis

    7.1. Global Hidradenitis Suppurativa Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Hidradenitis Suppurativa Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Hidradenitis Suppurativa Market

    8.1. Asia-Pacific Hidradenitis Suppurativa Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Hidradenitis Suppurativa Market

    9.1. China Hidradenitis Suppurativa Market Overview

    9.2. China Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Hidradenitis Suppurativa Market

    10.1. India Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Hidradenitis Suppurativa Market

    11.1. Japan Hidradenitis Suppurativa Market Overview

    11.2. Japan Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Hidradenitis Suppurativa Market

    12.1. Australia Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Hidradenitis Suppurativa Market

    13.1. Indonesia Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Hidradenitis Suppurativa Market

    14.1. South Korea Hidradenitis Suppurativa Market Overview

    14.2. South Korea Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Hidradenitis Suppurativa Market

    15.1. Western Europe Hidradenitis Suppurativa Market Overview

    15.2. Western Europe Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Hidradenitis Suppurativa Market

    16.1. UK Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Hidradenitis Suppurativa Market

    17.1. Germany Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Hidradenitis Suppurativa Market

    18.5. France Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Hidradenitis Suppurativa Market

    19.9. Italy Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Hidradenitis Suppurativa Market

    20.13. Spain Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Hidradenitis Suppurativa Market

    21.1. Eastern Europe Hidradenitis Suppurativa Market Overview

    21.2. Eastern Europe Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Hidradenitis Suppurativa Market

    22.1. Russia Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Hidradenitis Suppurativa Market

    23.1. North America Hidradenitis Suppurativa Market Overview

    23.2. North America Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Hidradenitis Suppurativa Market

    24.1. USA Hidradenitis Suppurativa Market Overview

    24.2. USA Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Hidradenitis Suppurativa Market

    25.1. Canada Hidradenitis Suppurativa Market Overview

    25.2. Canada Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Hidradenitis Suppurativa Market

    26.1. South America Hidradenitis Suppurativa Market Overview

    26.2. South America Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Hidradenitis Suppurativa Market

    27.1. Brazil Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Hidradenitis Suppurativa Market

    28.1. Middle East Hidradenitis Suppurativa Market Overview

    28.2. Middle East Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Hidradenitis Suppurativa Market

    29.1. Africa Hidradenitis Suppurativa Market Overview

    29.2. Africa Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Hidradenitis Suppurativa Market Competitive Landscape And Company Profiles

    30.1. Hidradenitis Suppurativa Market Competitive Landscape

    30.2. Hidradenitis Suppurativa Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson & Johnson

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. AbbVie Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Novartis AG

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Bristol-Myers Squibb Company

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Hidradenitis Suppurativa Market Other Major And Innovative Companies

    31.1. AstraZeneca PLC

    31.2. Abbott Laboratories

    31.3. Eli Lilly and Co Ltd.

    31.4. Amgen Inc.

    31.5. Boehringer Ingelheim International GmbH

    31.6. UCB S.A.

    31.7. Incyte Corporation

    31.8. Kyowa Kirin Co. Ltd.

    31.9. Leo Pharma A/S

    31.10. Almirall S.A.

    31.11. Galapagos NV

    31.12. Genentech Inc.

    31.13. Tolmar Inc.

    31.14. Alvotech Holdings S.A.

    31.15. Aclaris Therapeutics Inc.

    32. Global Hidradenitis Suppurativa Market Competitive Benchmarking

    33. Global Hidradenitis Suppurativa Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Hidradenitis Suppurativa Market

    35. Hidradenitis Suppurativa Market Future Outlook and Potential Analysis

    35.1 Hidradenitis Suppurativa Market In 2028 - Countries Offering Most New Opportunities

    35.2 Hidradenitis Suppurativa Market In 2028 - Segments Offering Most New Opportunities

    35.3 Hidradenitis Suppurativa Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Hidradenitis Suppurativa Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Global Hidradenitis Suppurativa Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: Asia-Pacific, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: China, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: India, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Japan, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Australia, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: Indonesia, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: South Korea, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Western Europe, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: UK, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: Germany, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: France, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Italy, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Spain, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Eastern Europe, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: Russia, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: North America, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: USA, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: Canada, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: South America, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Brazil, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Middle East, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Africa, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 76: Pfizer Inc. Financial Performance
  • Table 77: Johnson & Johnson Financial Performance
  • Table 78: AbbVie Inc. Financial Performance
  • Table 79: Novartis AG Financial Performance
  • Table 80: Bristol-Myers Squibb Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Hidradenitis Suppurativa Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Global Hidradenitis Suppurativa Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: Asia-Pacific, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: China, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: India, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Japan, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Australia, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: Indonesia, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: South Korea, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Western Europe, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: UK, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: Germany, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: France, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Italy, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Spain, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Eastern Europe, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: Russia, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: North America, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: USA, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: Canada, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: South America, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Brazil, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Middle East, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Africa, Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 76: Pfizer Inc. Financial Performance
  • Figure 77: Johnson & Johnson Financial Performance
  • Figure 78: AbbVie Inc. Financial Performance
  • Figure 79: Novartis AG Financial Performance
  • Figure 80: Bristol-Myers Squibb Company Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2024 – By Product Type (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars ), By Route Of Administration (Subcutaneous Injection, Intravenous Injection ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies ), By Application (Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Crohn’s Disease, Ulcerative Colitis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Other Applications ) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Support Activities For Printing Global Market Report 2024 – By Type (Pre-Press Services, Post-Press Services), By Organization size (Small Enterprise, Medium Enterprise, Large Enterprise), By Application (Household, Commercial) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Printing And Related Support Activities Global Market Report 2024 – By Type (Printing, Support Activities For Printing), By Technology (Flexography Printing, Rotogravure Printing, Digital Printing, OffSet Printing, Other Technologies), By Application (Packaging, Advertising, Publishing, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Hospital Supplies Global Market Report 2024 – By Type (Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users), By Type of Expenditure (Public, Private), By Product (Instruments Equipment, Disposables) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Office Supplies (Except Paper) Global Market Report 2024 – By Type (Business Forms, Stationery, Storage Containers, and Other Types), By Product Type (Desk, Filling, Binding, Computer or Printer, Other Product Types), By Application (Enterprises, Household, Educational Institutions, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Hardware Support Services Global Market Report 2024 – By Type (Networking Support Services, Storage And Servers Support Services, Computer And Peripherals Support Services, Other Hardware Support Services), By Mode (Offline, Online), By Warranty Type (In Warranty, Out Of Warranty) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Building Material and Garden Equipment and Supplies Dealers Global Market Report 2024 – By Type (Building Material and Supplies Dealers, Lawn and Garden Equipment and Supplies Stores), By Ownership (Retail Chain, Independent Retailer), By Type of Store (Exclusive Retailers Showroom, Inclusive Retailers Dealer Store) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Steam & Air-Conditioning Supply Global Market Report 2024 – By Type (Distribution Of Steam and Heated Air, and Distribution Of Cooled Air), By Distribution Channel (Multi-Brand Stores, Exclusive Stores, Online, and Other Distribution Channels), By End User (Residential, Commercial) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the hidradenitis suppurativa market?

Hidradenitis suppurativa (HS) is a chronic skin condition that causes painful lumps deep in the skin, usually on parts of the body where skin touches the skin, like the armpits, inner thighs, and groin area. These lumps frequently appear where skin contacts skin, such as the armpits, inner thighs, and groin. For further insights on the hidradenitis suppurativa market, request a sample here

How will the hidradenitis suppurativa market drivers and restraints affect the hidradenitis suppurativa market dynamics? What forces will shape the hidradenitis suppurativa industry going forward?

The hidradenitis suppurativa market major growth driver - The Rise In The Prevalence Of Skin Diseases . For further insights on the hidradenitis suppurativa market, request a sample here

What is the forecast market size or the forecast market value of the hidradenitis suppurativa market?

The hidradenitis suppurativamarket size has grown strongly in recent years. It will grow from $1.06 billion in 2023 to $1.15 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increased diagnosis awareness, limited treatment options, advancements in dermatology, rising disease prevalence, patient advocacy initiatives. The hidradenitis suppurativamarket size is expected to see strong growth in the next few years. It will grow to $1.5 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to biologic therapies development, precision medicine approaches, clinical trial expansion, global initiatives and funding, healthcare policy support. Major trends in the forecast period include advanced immunomodulatory therapies, telemedicine and remote monitoring, patient-centric care, minimally invasive surgical interventions, personalized lifestyle recommendations. For further insights on the hidradenitis suppurativa market, request a sample here

How is the hidradenitis suppurativa market segmented?

The hidradenitis suppurativa market is segmented
1) By Skin Condition: Folliculitis, Pimples, Boils, Deep-Acne
2) By Product: Tablet, Intravenous (IV) Injection
3) By Route Of Administration: Oral, Parenteral
4) By Treatment: Medications, Surgery, Photodynamic Therapy (PDT), Laser Treatment, Other Treatments
5) By End User: Hospital, Specialty Clinic, Homecare, Other End UsersFor further insights on the hidradenitis suppurativa market, request a sample here

Which region has the largest share of the hidradenitis suppurativa market? What are the other regions covered in the report?

North America was the largest region in the hidradenitis suppurativamarket in 2023. The regions covered in the hidradenitis suppurativa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the hidradenitis suppurativa market, request a sample here.

Who are the major players in the hidradenitis suppurativa market?

Major companies operating in the hidradenitis suppurativa market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, UCB S.A., Incyte Corporation, Kyowa Kirin Co. Ltd., Leo Pharma A/S, Almirall S.A., Galapagos NV, Genentech Inc., Tolmar Inc., Alvotech Holdings S.A., Aclaris Therapeutics Inc., Kymera Therapeutics Inc., Acelyrin Inc., AnaptysBio Inc., XBiotech Inc., Arcutis Biotherapeutics Inc., InflaRx N.V., VYNE Therapeutics Inc., Arena Pharmaceuticals Inc., MoonLake Immunotherapeutics AG, Zynerba Pharmaceuticals Inc. For further insights on the hidradenitis suppurativa market, request a sample here.

What are the key trends in the hidradenitis suppurativa market?

Major trend in the hidradenitis suppurativa market - Transforming Hidradenitis Suppurativa Treatment Through Innovative Therapies . For further insights on the hidradenitis suppurativa market, request a sample here.

What are the major opportunities in the hidradenitis suppurativa market? What are the strategies for the hidradenitis suppurativa market?

For detailed insights on the major opportunities and strategies in the hidradenitis suppurativa market, request a sample here.

How does the hidradenitis suppurativa market relate to the overall economy and other similar markets?

For detailed insights on hidradenitis suppurativa market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the hidradenitis suppurativa industry?

For detailed insights on the mergers and acquisitions in the hidradenitis suppurativa industry, request a sample here.

What are the key dynamics influencing the hidradenitis suppurativa market growth? SWOT analysis of the hidradenitis suppurativa market.

For detailed insights on the key dynamics influencing the hidradenitis suppurativa market growth and SWOT analysis of the hidradenitis suppurativa industry, request a sample here.